Gene · 9833
Papers1,515
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 1,515
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Mechanisms of copper metabolism and cuproptosis: implications for liver diseases. | Front Immunol | 2025 | 40808953 | PubTator, text mining | PubMed |
| Plumbagin Triggers Cuproptosis in Hepatocellular Carcinoma (HCC) via the DNA-Methyltransferase 1 (DNMT1)/microRNA-302a-3p (miR-302a-3p)/ATPase Copper Transporting Beta (ATP7B) Axis. | MedComm (2020) | 2025 | 40761482 | PubTator, text mining | PubMed |
| Unequal segregation of mitochondria during asymmetric cell division contributes to cell fate divergence in sister cells in vivo. | Nat Commun | 2025 | 40759648 | PubTator, text mining | PubMed |
| CRISPR/Cas9-based discovery of ccRCC therapeutic opportunities through molecular mechanism and immune microenvironment analysis. | Front Immunol | 2025 | 40709174 | PubTator, text mining | PubMed |
| Identification of biomarkers and exploration of mechanisms for atopic dermatitis based on transcriptome and scRNA-seq data analysis. | Medicine (Baltimore) | 2025 | 40629565 | PubTator, text mining | PubMed |
| MCM4 as Potential Metastatic Biomarker in Lung Adenocarcinoma. | Diagnostics (Basel) | 2025 | 40564876 | PubTator, text mining | PubMed |
| Screening kinase inhibitors identifies MELK as a prime target against influenza virus infections through inhibition of viral mRNA splicing. | Front Microbiol | 2025 | 40539108 | PubTator, text mining | PubMed |
| Integrated analysis of uterine leiomyosarcoma and leiomyoma utilizing TCGA and GEO data: a WGCNA and machine learning approach. | Transl Cancer Res | 2025 | 40530152 | PubTator, text mining | PubMed |
| Maternal Embryonic Leucine Zipper Kinase (MELK) as a Promising Therapeutic Target in Triple Negative Breast Cancer. | Anticancer Agents Med Chem | 2025 | 40417748 | PubTator, text mining | PubMed |
| MiR-485-3p/MELK cascade mediates tumor progression in pancreatic cancer. | Sci Rep | 2025 | 40404813 | PubTator, text mining | PubMed |
| CPI203, a BET inhibitor, down-regulates a consistent set of DNA synthesis genes across a wide array of glioblastoma lines. | PLoS One | 2025 | 40378113 | PubTator, text mining | PubMed |
| GJB2 as a novel prognostic biomarker associated with immune infiltration and cuproptosis in ovarian cancer. | Apoptosis | 2025 | 40375037 | PubTator, text mining | PubMed |
| A Perspective on the Strategic Application of Deconstruction-Reconstruction in Drug Discovery. | J Med Chem | 2025 | 40324045 | PubTator, text mining | PubMed |
| MELK as a Mediator of Stemness and Metastasis in Aggressive Subtypes of Breast Cancer. | Int J Mol Sci | 2025 | 40076867 | PubTator, text mining | PubMed |
| Development and validation of a kinase-related gene signature as a novel diagnostic and prognostic model for prostate cancer. | Biochim Biophys Acta Mol Basis Dis | 2025 | 39965532 | PubTator, text mining | PubMed |
| Integrative Bioinformatics Analysis for Targeting Hub Genes in Hepatocellular Carcinoma Treatment. | Curr Genomics | 2025 | 39911278 | PubTator, text mining | PubMed |
| MELK prevents radiofrequency ablation-induced immunogenic cell death and antitumor immune response by stabilizing FABP5 in hepatocellular malignancies. | Mil Med Res | 2025 | 39871325 | PubTator, text mining | PubMed |
| Phytochemical-Based Drug Discovery for Breast Cancer: Combining Virtual Screening and Molecular Dynamics to Identify Novel Therapeutics. | Chem Biodivers | 2025 | 39868843 | PubTator, text mining | PubMed |
| Exploring the mechanism and drug candidates of alveolar echinococcosis affecting liver fibrosis through analysis of existing microarray data. | Acta Trop | 2025 | 39863141 | PubTator, text mining | PubMed |
| Potential Biomarkers for Predicting the Risk of Developing Into Long COVID After COVID-19 Infection. | Immun Inflamm Dis | 2025 | 39853911 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9833/papers?page=4